|
|
|
Volumn 27, Issue 3 SUPPL. 5, 2000, Pages 82-89
|
|
Nonmyeloablative approaches to the treatment of sickle hemoglobinopathies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALEMTUZUMAB;
ANTICOAGULANT AGENT;
BUSULFAN;
CISPLATIN;
CLADRIBINE;
CLOTRIMAZOLE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DESMOPRESSIN ACETATE;
DIPYRIDAMOLE;
FLUDARABINE;
HEPARIN;
HYDROXYUREA;
IDARUBICIN;
MAGNESIUM;
NITRIC OXIDE;
PENTOSTATIN;
THYMOCYTE ANTIBODY;
BLOOD BANK;
BLOOD DONOR;
BONE MARROW TRANSPLANTATION;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONFERENCE PAPER;
GRAFT VERSUS HOST REACTION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
MOLECULAR BIOLOGY;
PRIORITY JOURNAL;
SICKLE CELL ANEMIA;
ADULT;
ANEMIA, SICKLE CELL;
BONE MARROW TRANSPLANTATION;
CHILD;
FETAL HEMOGLOBIN;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
PENTOSTATIN;
PURINE NUCLEOSIDES;
REMISSION INDUCTION;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 0033944194
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (11)
|
|
References (45)
|
